ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 100 filers reported holding ARATANA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $272,000 | -62.8% | 52,783 | -74.0% | 0.00% | -66.7% |
| Q1 2019 | $732,000 | -41.3% | 203,283 | 0.0% | 0.01% | -47.1% |
| Q4 2018 | $1,246,000 | +31.0% | 203,283 | +24.9% | 0.02% | +88.9% |
| Q3 2018 | $951,000 | +37.4% | 162,783 | 0.0% | 0.01% | +28.6% |
| Q2 2018 | $692,000 | -3.6% | 162,783 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $718,000 | -21.8% | 162,783 | -6.8% | 0.01% | -20.0% |
| Q4 2017 | $918,000 | +11.1% | 174,583 | +29.5% | 0.01% | +11.1% |
| Q3 2017 | $826,000 | -15.2% | 134,783 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $974,000 | +36.4% | 134,783 | 0.0% | 0.01% | +33.3% |
| Q1 2017 | $714,000 | +14.2% | 134,783 | +55.0% | 0.01% | +12.5% |
| Q4 2016 | $625,000 | -23.2% | 86,983 | 0.0% | 0.01% | -33.3% |
| Q3 2016 | $814,000 | +48.0% | 86,983 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $550,000 | +112.4% | 86,983 | +85.1% | 0.01% | +125.0% |
| Q1 2016 | $259,000 | – | 46,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |